GSK_Annual_Report_2021

Notes to the Standalone Financial Statements for the year ended March 31, 2021 (contd.) Financial Statements GlaxoSmithKline Pharmaceuticals Limited 128 Note 40 : Contingent liabilities ( ` in lakhs) As at March 31, 2021 As at March 31, 2020 A. Contingent Liabilities not provided for: (i) Cheques discounted with banks 10,51.84 16,77.01 (ii) In respect of claims made against the Company not acknowledged as debts by the Company (a) Sales tax matters 58,20.80 57,83.08 (b) Excise and custom matters 8,75.87 8,31.50 (c) Service tax matters 1,29.20 1,29.20 (d) Labour matters 61,45.39 60,11.73 (e) Other legal matters (Refer Note 42) 24,98.43 24,98.43 154,69.69 152,53.94 (iii) Income-tax matters in respect of which appeals are pending Tax on matters in dispute 320,56.61 302,11.00 Notes: Future cash outflows in respect of (i) above are dependant on the return of cheques by banks. Future cash outflows in respect of (ii) above are determinable on receipt of decisions / judgements pending with various forums / authorities, hence it is not practicable for the Company to estimate the timing of cash outflow, if any. The Company does not expect any reimbursement in respect of above contingent liabilities. ( ` in lakhs) As at March 31, 2021 As at March 31, 2020 B. Commitments (i) Estimated amount of contracts (net of advances) remaining to be executed on capital account and not provided for 7,45.59 11,61.90 (Refer Note (a) below) (ii) Uncalled liability on partly paid shares: - in Hill Properties Limited 0.04 0.04 (Refer note (b) below) Notes: (a) Estimated amount of contracts (net of advances) remaining to be executed on capital account and not provided for as at March 31, 2021 mainly comprises the investments in the capital assets at corporate office and site and as at March 31, 2020 mainly comprised the ongoing investments in the corporate office renovations and other miscellaneous capitalisations at site. (b) Future cash outflow is dependent on the call to be made by Hill Properties Limited.